(Q37976853)

English

Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment

scientific article published on February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 August 2017

0 references

Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment (English)

1 reference

Europe PubMed Central

26 August 2017

Alzheimer's disease

0 references

0 references

mild cognitive impairment

1 reference

based on heuristic

inferred from title

author name string

S Zhang

1

1 reference

Europe PubMed Central

26 August 2017

D Han

2

1 reference

Europe PubMed Central

26 August 2017

X Tan

3

1 reference

Europe PubMed Central

26 August 2017

J Feng

4

1 reference

Europe PubMed Central

26 August 2017

Y Guo

5

1 reference

Europe PubMed Central

26 August 2017

Y Ding

6

1 reference

Europe PubMed Central

26 August 2017

publication date

1 February 2012

1 reference

Europe PubMed Central

26 August 2017

International Journal of Clinical Practice

1 reference

Europe PubMed Central

26 August 2017

66

1 reference

Europe PubMed Central

26 August 2017

2

1 reference

Europe PubMed Central

26 August 2017

185-198

1 reference

Europe PubMed Central

26 August 2017

Mild cognitive impairment as a diagnostic entity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Neuroimaging through the course of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Imaging of mild cognitive impairment and early dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Frequent amyloid deposition without significant cognitive impairment among the elderly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

PET imaging of amyloid deposition in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Current concepts in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Amyloid imaging in mild cognitive impairment subtypes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Comparing predictors of conversion and decline in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Principal component analysis of FDG PET in amnestic MCI.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Amyloid imaging in early detection of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Comparison of 18F-FDG and PiB PET in cognitive impairment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Meta-analysis of diagnostic test studies using individual patient data and aggregate data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02845.X

21 January 2018

Identifiers

10.1111/J.1742-1241.2011.02845.X

1 reference

https://api.fatcat.wiki/v0/release/b4ticoyfsvg57lgx27niqd4pu4

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_b4ticoyfsvg57lgx27niqd4pu4

1 reference

https://api.fatcat.wiki/v0/release/b4ticoyfsvg57lgx27niqd4pu4

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/b4ticoyfsvg57lgx27niqd4pu4

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37976853&oldid=1801307183"